ABBAS HUSSAIN

Corporate Board Profile

Tech Score: 0/100

TEVA PHARMACEUTICAL INDUSTRIES LTD

Filing Date	Source Excerpt
2021-04-21	Abbas Hussain Independent Director Committees: Audit, Finance and Investment, Science and Technology Mr. Hussain joined the Board of Directors in September 2020. Mr. Hussain has served on the board of directors of Cochlear Limited and CSL Limited, both since 2018. From 2008 to 2017, Mr. Hussain held senior executive positions at GlaxoSmithKline plc (GSK), including Global President, Pharmaceuticals and Vaccines from 2013 to 2017, President, Europe and Emerging Markets, Pharmaceuticals from 2011 to 2013 and President, Emerging Markets, Pharmaceuticals from 2008 to 2011. Prior to joining GSK, he held senior roles with global responsibility at Eli Lilly and Company from 1998 to 2008, including President, European Operations from 2006 to 2008. Mr. Hussain has Joint Honors in medicinal chemistry and pharmacology from Loughborough Institute of Technology. 2020 Director Compensation: Abbas Hussain Fees Earned or Paid in Cash ($) 50,000 Stock Awards ($) 122,670 Total ($) 172,670

Filing Date

Source Excerpt

2021-04-21

Abbas Hussain Independent Director Committees: Audit, Finance and Investment, Science and Technology Mr. Hussain joined the Board of Directors in September 2020. Mr. Hussain has served on the board of directors of Cochlear Limited and CSL Limited, both since 2018. From 2008 to 2017, Mr. Hussain held senior executive positions at GlaxoSmithKline plc (GSK), including Global President, Pharmaceuticals and Vaccines from 2013 to 2017, President, Europe and Emerging Markets, Pharmaceuticals from 2011 to 2013 and President, Emerging Markets, Pharmaceuticals from 2008 to 2011. Prior to joining GSK, he held senior roles with global responsibility at Eli Lilly and Company from 1998 to 2008, including President, European Operations from 2006 to 2008. Mr. Hussain has Joint Honors in medicinal chemistry and pharmacology from Loughborough Institute of Technology. 2020 Director Compensation: Abbas Hussain Fees Earned or Paid in Cash ($) 50,000 Stock Awards ($) 122,670 Total ($) 172,670

Data sourced from SEC filings. Last updated: 2025-12-06